查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1808877

心臟肌钙蛋白市场（按产品类型、按测试类型、按最终用户、按国家和地区）—2025 年至 2032 年全球产业分析、市场规模、市场份额和预测

Cardiac Troponin Market, By Product Type, By Test Type, By End-user, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 392 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2024 年心臟肌钙蛋白市场规模价值为 33.4512 亿美元，2025 年至 2032 年的复合年增长率为 8.5%。

心肌肌钙蛋白市场围绕着测量血液中肌钙蛋白水平的诊断检测产品的生产和销售。肌钙蛋白是检测心肌损伤的关键生物标记物，尤其是在心肌梗塞（心臟病发作）等情况下。心肌肌钙蛋白（cTnI 和 cTnT）是心臟受损时释放到血液中的蛋白质，因此是心臟事件的高度敏感和特异性指标。心血管疾病 (CVD) 盛行率的上升、对早期准确诊断的需求不断增长，以及高敏肌钙蛋白检测（hs-cTn 检测）的进步，共同推动着该市场的发展。

这些检测能够更快发现心臟病发作，改善患者的预后。医院、诊断实验室和急诊中心是主要的终端使用者。主要参与者包括雅培实验室、罗氏诊断、西门子医疗和贝克曼库尔特，他们透过创新和监管审批展开竞争。由于人口老化、久坐不动的生活方式以及人们对心臟健康的日益关注，市场正在扩大。然而，高昂的成本和严格的监管要求等挑战也随之而来。

心臟肌钙蛋白市场-市场动态

紧急诊断中对高敏肌钙蛋白检测的需求不断增长

心肌肌钙蛋白市场的关键驱动力。这些先进的检测方法甚至可以检测血液中微量的肌钙蛋白，与传统检测方法相比，能够更早、更准确地诊断心臟病发作。急诊室依靠高敏感肌钙蛋白（hs-cTn）检测快速确诊或排除心肌梗塞，从而改善患者分诊并减少不必要的住院。随着全球心血管疾病（CVD）的发生率不断上升，快速且精准的诊断对于获得更好的治疗效果至关重要。高敏感性检测方法可以更快地做出决策，尤其是在症状可能不明确的非ST段抬高型心肌梗塞（NSTEMI）病例中。高敏肌钙蛋白检测方法的监管批准以及相关指南的建议使用，进一步推动了市场的成长。

医院和诊断实验室越来越多地采用这些检测来提高急诊护理的效率。因此，领先的诊断公司正在投资下一代高敏感性肌钙蛋白（hs-cTn）检测，推动心肌肌钙蛋白市场的创新和竞争。随着医疗保健系统优先考虑更快、更可靠的心臟诊断，预计这一趋势将持续下去。

心臟肌钙蛋白市场-关键见解

根据我们的研究分析师的分析，预计全球市场在预测期内（2025-2032 年）的年复合成长率约为 8.5%。

根据产品类型细分，高敏感性心肌肌钙蛋白 (hs-cTn) 检测预计将在 2024 年占据最大市场份额

根据检测类型细分，肌钙蛋白 I 检测是 2024 年领先的检测类型

根据最终用户细分，医院和急诊室是 2024 年的主要最终用户

从地区来看，北美是 2024 年最大的收入来源

心臟肌钙蛋白市场-細項分析：

全球心臟肌钙蛋白市场根据产品类型、测试类型、最终用户和地区进行细分。

根据产品类型，市场分为三类：高敏感度心肌肌钙蛋白检测、常规心肌肌钙蛋白检测和即时诊断心肌肌钙蛋白检测。高敏感度心肌肌钙蛋白 (hs-cTn) 检测因其在心肌梗塞早期准确诊断中的卓越临床实用性，在心肌肌钙蛋白市场占据主导地位。与常规检测相比，这些先进的检测方法可以检测到血液中明显较低的肌钙蛋白水平，使医生能够更快地识别心臟损伤，通常在症状出现后 1-2 小时内即可发现。这种快速检测在紧急情况下至关重要，及时介入可以改善患者预后并降低死亡率。

临床指引（例如ESC和ACC建议）优先将hs-cTn检测用于诊断急性冠状动脉综合征，这进一步巩固了hs-cTn检测的主导地位。医院和实验室越来越多地采用这些检测，因为它们可以降低诊断不确定性，最大​​限制地减少不必要的住院，并提高工作流程效率。此外，罗氏、雅培和西门子等领先的诊断公司大力投资高灵敏度检测，推动创新和市场渗透。

根据检测类型，市场分为两类：肌钙蛋白 I 和肌钙蛋白 T。肌钙蛋白 I (cTnI) 在心肌肌钙蛋白检测领域占据主导地位，占据全球最大市场。这种优势源自于几个关键优势：cTnI 检测表现出卓越的心臟特异性，因为肌钙蛋白 I 仅在心肌中表达，而肌钙蛋白 T 则与骨骼肌的交叉反应性较小。雅培实验室和贝克曼库尔特等主要诊断公司已在 cTnI 检测方面投入巨资，雅培的高敏肌钙蛋白 I 检测已成为美国和欧洲市场的领导者。

cTnI 细分市场的成长得益于其在急性冠状动脉综合症临床指引和标准化诊断方案中的广泛应用。与肌钙蛋白 T（主要由罗氏专有的 Elecsys 平台控制）不同，肌钙蛋白 I 检测试剂来自多家製造商，这使得市场竞争更加激烈。此外，cTnI 检测在某些患者群体（包括肾病患者）中表现出更佳的分析性能。虽然肌钙蛋白 T 仍然很重要（尤其是在罗氏主导的市场中），但肌钙蛋白 I 的心臟特异性、多供应商供应以及与不断发展的高灵敏度检测要求的契合度，巩固了其作为现代心臟护理首选生物标誌物的地位。

心臟肌钙蛋白市场-地理洞察

北美心肌肌钙蛋白市场在全球占据主导地位，这得益于其先进的医疗基础设施、较高的心血管疾病患病率以及高敏肌钙蛋白 (hs-cTn) 检测的快速普及。美国凭藉其强大的报销政策、FDA 对先进检测的批准以及在急诊室的广泛应用，占据领先地位。

加拿大紧随其后，加大了对心臟护理的投入，并制定了标准化指南来推广高敏肌钙蛋白（hs-cTn）检测。雅培、罗氏和西门子等主要诊断公司在该地区拥有强大的影响力，促进了竞争和创新。严格的监管标准确保了高品质的诊断，而人们对早期心臟病发作检测意识的不断提高也进一步刺激了需求。该地区对精准医疗和人工智慧整合诊断的关注将继续推动市场成长。

心臟肌钙蛋白市场-竞争格局：

心肌肌钙蛋白市场的竞争格局以全球诊断巨头之间的激烈竞争为特征，其驱动力包括创新、监管审批和策略合作。雅培实验室、罗氏诊断和西门子医疗凭藉其先进的高敏肌钙蛋白 (hs-cTn) 检测技术和强大的终端用户网络，占据市场主导地位。这些公司在准确性、速度和临床实用性方面展开竞争，其中罗氏的 Elecsys Troponin T 和雅培的 Architect STAT hs-Troponin-I 在应用方面处于领先地位。

QuidelOrtho、bioMerieux 和 Beckman Coulter 等中型企业专注于利基市场，例如即时检验 (POCT) 和自动化实验室系统；而 Randox Laboratories 和 Getein Biotech 等新兴企业则瞄准成本敏感型市场，提供价格实惠的替代方案。併购活动（例如 Quidel 与 Ortho Clinical Diagnostics 的合併）正在重塑市场格局，提升技术能力。

最新动态：

2024 年 6 月，雅培实验室 (Abbott Laboratories) 获得 FDA 批准，可在 Alinity ci 系列分析仪上进行下一代高灵敏度肌钙蛋白 I 检测，从而能够在美国医院更快地进行 MI 诊断。

目录

第一章：心臟肌钙蛋白市场概述

  • 研究范围
  • 市场估计年限

第二章：执行摘要

  • 市场片段
    • 心臟肌钙蛋白市场片段（依产品类型）
    • 心臟肌钙蛋白市场片段（依测试类型）
    • 心臟肌钙蛋白市场片段（按最终用户）
    • 心臟肌钙蛋白市场（按国家/地区）
    • 心臟肌钙蛋白市场（按地区）
  • 竞争洞察

第三章：心臟肌钙蛋白主要市场趋势

  • 心臟肌钙蛋白市场驱动因素
    • 市场驱动因素的影响分析
  • 心臟肌钙蛋白市场限制
    • 市场限制的影响分析
  • 心臟肌钙蛋白的市场机会
  • 心臟肌钙蛋白市场未来趋势

第四章：心臟肌钙蛋白产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第五章：心臟肌钙蛋白市场：地缘政治紧张局势升级的影响

  • COVID-19 疫情的影响
  • 俄乌战争的影响
  • 中东衝突的影响

第六章：心臟肌钙蛋白市场格局

  • 2024年心臟肌钙蛋白市占分析
  • 按主要製造商分類的细分数据
    • 成熟玩家分析
    • 新兴企业分析

第七章：心臟肌钙蛋白市场－依产品类型

  • 概述
    • 按产品类型分類的细分市场占有率分析
    • 高敏感度心肌肌钙蛋白检测
    • 常规心臟肌钙蛋白检测
    • 即时肌钙蛋白检测

第 8 章：心臟肌钙蛋白市场 - 依测试类型

  • 概述
    • 按测试类型分類的细分市场份额分析
    • 肌钙蛋白I
    • 肌钙蛋白T

第九章：心臟肌钙蛋白市场－按最终用户

  • 概述
    • 按最终用户细分的份额分析
    • 医院和急诊科
    • 诊断和临床实验室
    • 门诊手术中心
    • 其他的

第 10 章：心臟肌钙蛋白市场 - 按地区

  • 介绍
    • 按地区分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美心臟肌钙蛋白主要製造商
    • 北美市场规模及预测（按国家/地区）
    • 北美市场规模和预测（按产品类型）
    • 北美市场规模和预测（按测试类型）
    • 北美市场规模及预测（按最终用户）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲心肌肌钙蛋白主要製造商
    • 欧洲市场规模及预测（按国家/地区）
    • 欧洲市场规模和预测（按产品类型）
    • 欧洲市场规模和预测（按测试类型）
    • 欧洲市场规模及预测（按最终用户）
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 荷兰
    • 瑞典
    • 俄罗斯
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区心臟肌钙蛋白主要製造商
    • 亚太地区市场规模及预测（依国家）
    • 亚太地区市场规模及预测（依产品类型）
    • 亚太地区市场规模及预测（依测试类型）
    • 亚太地区市场规模及预测（依最终用户）
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 印尼
    • 泰国
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲（LATAM）
    • 概述
    • 拉丁美洲心臟肌钙蛋白主要製造商
    • 拉丁美洲市场规模及预测（按国家/地区）
    • 拉丁美洲市场规模及预测（依产品类型）
    • 拉丁美洲市场规模及预测（按测试类型）
    • 拉丁美洲市场规模及预测（按最终用户）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲（MEA）
    • 概述
    • 中东和非洲的心臟肌钙蛋白主要製造商
    • MEA 市场规模及预测（依国家/地区）
    • MEA 市场规模及预测（依产品类型）
    • MEA 市场规模及预测（依测试类型）
    • MEA 市场规模及预测（依最终用户）
    • 沙乌地阿拉伯
    • 阿联酋
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 其余地区

第 11 章：心臟肌钙蛋白产业主要供应商分析

  • 竞争仪錶板
    • Competitive Benchmarking
    • Competitive Positioning
  • 公司简介
    • Abbott Laboratories
    • Roche Diagnostics
    • Siemens Healthineers
    • Beckman Coulter
    • bioMerieux
    • Thermo Fisher Scientific
    • QuidelOrtho
    • Becton Dickinson
    • Sysmex Corporation
    • PerkinElmer
    • Bio-Rad Laboratories
    • Fujirebio
    • DiaSorin
    • Randox Laboratories
    • Tosoh Corporation
    • Ortho Clinical Diagnostics
    • Merck KGaA
    • ELITechGroup
    • Getein Biotech
    • Response Biomedical

第 12 章：360 度分析师视角

第 13 章：附录

  • 研究方法
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
简介目录
Product Code: ANV5510

Cardiac Troponin Market size was valued at US$ 3,345.12 Million in 2024, expanding at a CAGR of 8.5% from 2025 to 2032.

The cardiac troponin market revolves around the production and sale of diagnostic tests that measure troponin levels in the blood, which are critical biomarkers for detecting heart muscle damage, particularly in conditions like myocardial infarction (heart attack). Cardiac troponins (cTnI and cTnT) are proteins released into the bloodstream when the heart is injured, making them highly sensitive and specific indicators of cardiac events. The market is driven by the rising prevalence of cardiovascular diseases (CVDs), increasing demand for early and accurate diagnosis, and advancements in high-sensitivity troponin assays (hs-cTn tests).

These tests enable faster detection of heart attacks, improving patient outcomes. Hospitals, diagnostic labs, and emergency care centers are the primary end-users. Key players include Abbott Laboratories, Roche Diagnostics, Siemens Healthineers, and Beckman Coulter, who compete through innovation and regulatory approvals. The market is expanding due to aging populations, sedentary lifestyles, and growing awareness of cardiac health. However, challenges include high costs and stringent regulatory requirements.

Cardiac Troponin Market- Market Dynamics

Rising demand for high-sensitivity troponin tests in emergency diagnostics

Key driver of the cardiac troponin market. These advanced assays detect even minute levels of troponin in the blood, enabling earlier and more accurate diagnosis of heart attacks compared to conventional tests. Emergency departments rely on hs-cTn tests to quickly rule in or rule out myocardial infarction, improving patient triage and reducing unnecessary hospital admissions. With cardiovascular diseases (CVDs) on the rise globally, rapid and precise diagnosis is critical for better outcomes. High-sensitivity tests allow for faster decision-making, particularly in cases of non-ST-elevation myocardial infarction (NSTEMI), where symptoms may be ambiguous. Regulatory approvals for hs-cTn assays, along with guidelines recommending their use, further boost market growth.

Hospitals and diagnostic labs are increasingly adopting these tests to enhance efficiency in acute care settings. As a result, leading diagnostic companies are investing in next-generation hs-cTn tests, driving innovation and competition in the cardiac troponin market. This trend is expected to continue as healthcare systems prioritize faster, more reliable cardiac diagnostics.

Cardiac Troponin Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 8.5% over the forecast period (2025-2032)

Based on product type segmentation, High-Sensitivity Cardiac Troponin (hs-cTn) Tests were predicted to show maximum market share in the year 2024

Based on Test Type segmentation, Troponin I Tests were the leading Test Type in 2024

Based on End-user segmentation, Hospitals & Emergency Departments were the leading end-users in 2024

Based on region, North America was the leading revenue generator in 2024

Cardiac Troponin Market- Segmentation Analysis:

The Global Cardiac Troponin Market is segmented on the basis of Product Type, Test Type, End-user, and Region.

The market is divided into three categories based on product type: High-Sensitivity Cardiac Troponin Tests, Conventional Cardiac Troponin Tests, and Point-of-Care Troponin Tests. The High-Sensitivity Cardiac Troponin (hs-cTn) Tests segment dominates the cardiac troponin market due to its superior clinical utility in early and accurate diagnosis of myocardial infarction. These advanced assays can detect significantly lower levels of troponin in the blood compared to conventional tests, enabling physicians to identify heart damage much sooner, often within 1-2 hours of symptom onset. This rapid detection is critical in emergency settings, where timely intervention improves patient outcomes and reduces mortality rates.

The dominance of hs-cTn tests is further reinforced by clinical guidelines (e.g., ESC and ACC recommendations) that prioritize their use for diagnosing acute coronary syndromes. Hospitals and labs increasingly adopt these tests because they reduce diagnostic uncertainty, minimize unnecessary hospital admissions, and enhance workflow efficiency. Additionally, leading diagnostic companies like Roche, Abbott, and Siemens heavily invest in high-sensitivity assays, driving innovation and market penetration.

The market is divided into two categories based on Test Type: Troponin I, Troponin T. Troponin I (cTnI) dominates the cardiac troponin test type segment, holding the largest market share globally. This dominance stems from several key advantages: cTnI tests demonstrate superior cardiac specificity since troponin I is expressed exclusively in cardiac muscle, unlike troponin T, which shows minor skeletal muscle cross-reactivity. Major diagnostic players like Abbott Laboratories and Beckman Coulter have heavily invested in cTnI assays, with Abbott's High-Sensitivity Troponin-I test becoming a market leader in the U.S. and Europe.

The cTnI segment's growth is further propelled by its widespread adoption in clinical guidelines and standardized diagnostic protocols for acute coronary syndromes. Unlike troponin T (which is largely controlled by Roche's proprietary Elecsys platform), troponin I assays are available from multiple manufacturers, creating a more competitive market landscape. Additionally, cTnI tests show better analytical performance in certain patient populations, including those with renal disease. While troponin T remains important (particularly in Roche-dominated markets), troponin I's cardiac-specific nature, multi-vendor availability, and alignment with evolving high-sensitivity testing requirements cement its position as the preferred biomarker in modern cardiac care.

Cardiac Troponin Market- Geographical Insights

The North American cardiac troponin market dominates globally, driven by advanced healthcare infrastructure, high CVD prevalence, and rapid adoption of high-sensitivity troponin (hs-cTn) assays. The U.S. leads due to strong reimbursement policies, FDA approvals for advanced tests, and widespread use in emergency departments.

Canada follows closely, with increasing investments in cardiac care and standardized guidelines promoting hs-cTn testing. Major diagnostic players like Abbott, Roche, and Siemens have a strong presence, fueling competition and innovation. Strict regulatory standards ensure high-quality diagnostics, while rising awareness of early heart attack detection further boosts demand. The region's focus on precision medicine and AI-integrated diagnostics will continue shaping market growth.

Cardiac Troponin Market- Competitive Landscape:

The competitive landscape of the cardiac troponin market is characterized by intense rivalry among global diagnostics giants, driven by innovation, regulatory approvals, and strategic partnerships. Abbott Laboratories, Roche Diagnostics, and Siemens Healthineers dominate the market, leveraging their advanced high-sensitivity troponin (hs-cTn) assays and strong End-user networks. These players compete on accuracy, speed, and clinical utility, with Roche's Elecsys Troponin T and Abbott's Architect STAT hs-Troponin-I leading in adoption.

Mid-sized firms like QuidelOrtho, bioMerieux, and Beckman Coulter focus on niche segments, such as point-of-care testing (POCT) and automated lab systems, while emerging players like Randox Laboratories and Getein Biotech target cost-sensitive markets with affordable alternatives. Mergers and acquisitions (e.g., Quidel's merger with Ortho Clinical Diagnostics) are reshaping the market, enhancing technological capabilities.

Recent Developments:

In June 2024, Abbott Laboratories received FDA clearance for its next-gen High-Sensitivity Troponin-I assay on the Alinity ci-series analyzers, enabling faster MI diagnosis in U.S. hospitals.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL CARDIAC TROPONIN MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Abbott Laboratories
  • Roche Diagnostics
  • Siemens Healthineers
  • Beckman Coulter
  • bioMerieux
  • Thermo Fisher Scientific
  • QuidelOrtho
  • Becton Dickinson
  • Sysmex Corporation
  • PerkinElmer
  • Bio-Rad Laboratories
  • Fujirebio
  • DiaSorin
  • Randox Laboratories
  • Tosoh Corporation
  • Ortho Clinical Diagnostics
  • Merck KGaA
  • ELITechGroup
  • Getein Biotech
  • Response Biomedical

GLOBAL CARDIAC TROPONIN MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

  • High-Sensitivity Cardiac Troponin Tests
  • Conventional Cardiac Troponin Tests
  • Point-of-Care Troponin Tests

GLOBAL CARDIAC TROPONIN MARKET, BY TEST TYPE- MARKET ANALYSIS, 2019 - 2032

  • Troponin I
  • Troponin T

GLOBAL CARDIAC TROPONIN MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals & Emergency Departments
  • Diagnostic & Clinical Laboratories
  • Ambulatory Surgical Centers
  • Others

GLOBAL CARDIAC TROPONIN MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Cardiac Troponin Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Cardiac Troponin Market Snippet by Product Type
    • 2.1.2. Cardiac Troponin Market Snippet by Test Type
    • 2.1.3. Cardiac Troponin Market Snippet by End-user
    • 2.1.4. Cardiac Troponin Market Snippet by Country
    • 2.1.5. Cardiac Troponin Market Snippet by Region
  • 2.2. Competitive Insights

3. Cardiac Troponin Key Market Trends

  • 3.1. Cardiac Troponin Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Cardiac Troponin Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Cardiac Troponin Market Opportunities
  • 3.4. Cardiac Troponin Market Future Trends

4. Cardiac Troponin Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Cardiac Troponin Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Cardiac Troponin Market Landscape

  • 6.1. Cardiac Troponin Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Cardiac Troponin Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2024 & 2032 (%)
    • 7.1.2. High-Sensitivity Cardiac Troponin Tests
    • 7.1.3. Conventional Cardiac Troponin Tests
    • 7.1.4. Point-of-Care Troponin Tests

8. Cardiac Troponin Market - By Test Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Test Type, 2024 & 2032 (%)
    • 8.1.2. Troponin I
    • 8.1.3. Troponin T

9. Cardiac Troponin Market - By End-user

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End-user, 2024 & 2032 (%)
    • 9.1.2. Hospitals & Emergency Departments
    • 9.1.3. Diagnostic & Clinical Laboratories
    • 9.1.4. Ambulatory Surgical Centers
    • 9.1.5. Others

10. Cardiac Troponin Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Cardiac Troponin Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Cardiac Troponin Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.8. UK
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. UK Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4. UK Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.8.5. UK Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.9. France
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4. France Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.9.5. France Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.10. Italy
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4. Italy Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.10.5. Italy Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.11. Spain
      • 10.3.11.1. Overview
      • 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.3. Spain Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Spain Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.11.5. Spain Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.12. The Netherlands
      • 10.3.12.1. Overview
      • 10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.3. The Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.12.4. The Netherlands Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.12.5. The Netherlands Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Overview
      • 10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.13.5. Sweden Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.14. Russia
      • 10.3.14.1. Overview
      • 10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.3. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Russia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.14.5. Russia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.15. Poland
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Poland Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Poland Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.16. Rest of Europe
      • 10.3.16.1. Overview
      • 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.16.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.16.4. Rest of the Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.16.5. Rest of the Europe Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Cardiac Troponin Key Manufacturers in Asia Pacific
    • 10.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.4.5. APAC Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.4.6. APAC Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.7. China
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4. China Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.7.5. China Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.8. India
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4. India Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.8.5. India Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.12. Indonesia
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Indonesia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Indonesia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.13. Thailand
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Thailand Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Thailand Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.5. Latin America (LATAM)
    • 10.5.1. Overview
    • 10.5.2. Cardiac Troponin Key Manufacturers in Latin America
    • 10.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.5.5. LATAM Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.5.6. LATAM Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa (MEA)
    • 10.6.1. Overview
    • 10.6.2. Cardiac Troponin Key Manufacturers in Middle East and Africa
    • 10.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.6.5. MEA Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.6.6. MEA Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.6.8. UAE
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. UAE Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4. UAE Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.6.8.5. UAE Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Cardiac Troponin Industry

  • 11.1. Competitive Dashboard
    • 11.1.1. Competitive Benchmarking
    • 11.1.2. Competitive Positioning
  • 11.2. Company Profiles
    • 11.2.1. Abbott Laboratories
    • 11.2.2. Roche Diagnostics
    • 11.2.3. Siemens Healthineers
    • 11.2.4. Beckman Coulter
    • 11.2.5. bioMerieux
    • 11.2.6. Thermo Fisher Scientific
    • 11.2.7. QuidelOrtho
    • 11.2.8. Becton Dickinson
    • 11.2.9. Sysmex Corporation
    • 11.2.10. PerkinElmer
    • 11.2.11. Bio-Rad Laboratories
    • 11.2.12. Fujirebio
    • 11.2.13. DiaSorin
    • 11.2.14. Randox Laboratories
    • 11.2.15. Tosoh Corporation
    • 11.2.16. Ortho Clinical Diagnostics
    • 11.2.17. Merck KGaA
    • 11.2.18. ELITechGroup
    • 11.2.19. Getein Biotech
    • 11.2.20. Response Biomedical

12. 360 Degree AnalystView

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us